GlassScriptPhysician profile
Lynnea E Stines
NPI 1275984338
$1,585.14
in general payments reported to CMS, 2019-2025
21 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $60.55 · 2021: $297 · 2022: $254 · 2023: $223 · 2024: $403 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $849.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $387.29 | 2019-2022 | |
| Organon LLC | $235.42 | 2022-2025 | Jada System, Nexplanon |
| Mayne Pharma Commercial LLC | $169.77 | 2022-2025 | |
| Daiichi Sankyo INC. | $156.46 | 2020-2024 | Injectafer |
| Sumitomo Pharma America, INC. | $139.32 | 2023-2024 | Myfembree |
| Astellas Pharma US INC | $110.54 | 2023-2025 | Veozah |
| Biogen, INC. | $73.60 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $36.68 | 2022 | |
| Hologic Sales and Service, LLC | $34.90 | 2024 | Fluent Fluid Management System, Myosure Tissue Removal Device, Novasure |
| Novo Nordisk INC | $33.61 | 2021 | |
| Meditrina | $32.64 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $23.60 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $23.39 | 2023 | Exparel, Iovera |
| Octapharma USA, INC. | $23.01 | 2025 | Fibryga |
| Abbott Laboratories | $19.26 | 2023 | Proclaim |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $16.20 | 2025 | The Cologuard Plus Collection Kit |
| Pfizer INC. | $15.21 | 2023 | |
| Therapeuticsmd, INC. | $13.96 | 2020 | |
| Sanofi Pasteur INC. | $13.66 | 2024 | |
| Olympus America INC. | $13.42 | 2021 | |
| Smith+Nephew, INC. | $13.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynnea Stines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.